On 03 November, General Motors Company (NYSE:GM) shares advanced 0.59% and was closed at $35.78. GM EPS growth in last 5 year was -57.00%. General Motors Company (NYSE:GM) year to date (YTD) performance is 5.69%.
General Motors Company (NYSE:GM) warned the owners of 1.41 million older Chevys, Pontiacs, Buicks and Oldsmobiles not to park in garages or other structures indefinitely until it has a recall fix.Friday’s announcement came days after the Detroit automaker announced it was recalling the 1997-2004 Pontiac Grand Prix, 2000-04 Chevrolet Impala, 1998-99 Chevrolet Lumina, 1998-2004 Chevrolet Monte Carlo, 1998-99 Oldsmobile Intrigue and 1997-2004 Buick Regal “because drops of oil may be deposited on the hot exhaust manifold through hard braking, which can cause engine compartment fires. The recall covers cars with 3.8-liter V-6 3800 engines. There have been four recalls for the problem since 2008. All vehicles fixed earlier will need to be repaired again once GM has a new fix.
Albany Molecular Research Inc. (NASDAQ:AMRI) ended the last trading day at $18.99. Company weekly volatility is calculated as 4.67% and price to cash ratio as 15.80. Albany Molecular Research Inc. (NASDAQ:AMRI) showed a weekly performance of 4.11%.
Albany Molecular Research Inc. (NASDAQ:AMRI) announced that William S. Marth, AMRI’s President and Chief Executive Officer, will present at the Credit Suisse Healthcare Conference on Wednesday, November 11, 2015 at 9:00 a.m. MT.
On 03 November, Monster Beverage Corporation (NASDAQ:MNST) shares moved down -0.21% and was closed at $134.70. MNST EPS growth in last 5 year was 20.30%. Monster Beverage Corporation (NASDAQ:MNST) year to date (YTD) performance is 24.32%.
Monster Beverage Corporation (NASDAQ:MNST) announced that results for its third quarter ended September 30, 2015 will be released on Thursday, November 5, 2015 after the close of the market. The company also said that chairman and chief executive officer, Rodney Sacks, and vice chairman and president, Hilton Schlosberg, will host an investor conference call that same day at 2:00 p.m. Pacific Time to review the company’s financial results and operations.
Vascular Biogenics Ltd. (NASDAQ:VBLT) shares moved down -5.80% in last trading session and ended the day at $6.01. And its has a return on assets of -35.10%. Vascular Biogenics Ltd. (NASDAQ:VBLT) quarterly performance is 3.98%.
Vascular Biogenics Ltd. (NASDAQ:VBLT) announced the pricing of an underwritten offering of 2,500,000 ordinary shares together with accompanying warrants to purchase an aggregate of 1,250,000 ordinary shares. The combined offering price of each ordinary share and accompanying warrant was $6.00 per share. The gross proceeds to VBL Therapeutics from this offering are expected to be $15 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by VBL Therapeutics. The warrants will be exercisable at $7.50 per share, will be exercisable beginning on May 6, 2016 and will expire on May 6, 2021. The ordinary shares and warrants are immediately separable and will be issued separately.
West Corporation (NASDAQ:WSTC) caters to the Technology space. It has a net profit margin of 9.80% and weekly performance is 12.27%. On the last day of trading company shares ended up at $26.36. West Corporation (NASDAQ:WSTC) distance from 50-day simple moving average (SMA50) is 1.43%.
West Corporation (Nasdaq:WSTC), announced its third quarter 2015 results. For the third quarter of 2015, revenue was $574.4 million compared to $568.2 million for the same quarter of the previous year, an increase of 1.1 percent. Adjusted organic revenue growth was 3.9 percent for the quarter. Revenue from acquired entities3 was $5.4 million during the third quarter of 2015, contributing 0.9 percent to the Company’s revenue growth.
Leave a Reply